Research > ETFs > ETF / ETP Commentary > 

Opportunity Abounds With This Japan ETF

As of May 4, the MSCI Japan Index holds a year-to-date advantage of 450 basis points over the S&P 500. Investors could be doing even better, though, with more unique approaches to Japan equities. Just look at the WisdomTree Japan Opportunities Fund (OPPJ A-). Up 22.5% year-to-date, that ETF is beating the S&P 500 by a margin of better than 4-to-1, while more than doubling the returns of the MSCI Japan Index. OPPJ’s run undoubtedly impresses, particularly when considering that it was accrued in barely more than four months. However, that doesn’t imply that this ETF doesn’t have more gas in its tank.See more: ETF of the Week: WisdomTree Japan Opportunities Fund Actually, a case can be made that the Japan ETF has more room to run to the upside, particularly with recent data suggesting foreign investors are again buying Japan stocks.OPPJ Has TailwindsOPPJ appears to be at the right place at the right time, because Japan stocks are more attractively valued than the S&P 500. Alone, that’s reason enough to spark interest among some asset allocators. “Japanese equities were still attracting strong foreign inflows tied to optimism around AI and technology stocks. For many portfolio managers, this is no longer just a regional trade. It is a decision about where upside looks cleaner from here,” reported News on Japan. Japan tech stocks, which are OPPJ’s second-largest sector weight at 11.59%, are particularly alluring for foreign investors. Put simply, while U.S. large-cap tech names have momentum, Japan tech names offer momentum and value. “That combination matters. In the United States, many large technology names already carry rich valuations, so investors have become more selective. In Japan, by contrast, the story feels earlier in the cycle. The companies are well known, the AI theme is real, and the pricing still looks less stretched,” according to News on Japan. So with OPPJ, it’s possible for investors to have their cake (artificial intelligence exposure) and eat it too (upside potential). Meanwhile, they don’t have to embrace rich valuations for the privilege. These days, that may be enough for many investors. “The Nikkei 225 is outperforming because it sits at the intersection of two powerful ideas: renewed foreign interest in Japan and a search for tech exposure that does not look as expensive as Wall Street. That is a compelling mix, especially while the S&P 500 faces tougher scrutiny on valuation and market sensitivity to oil and geopolitics,” concluded News on Japan. For more news, information, and analysis, visit the Modern Alpha Content Hub.DisclosuresThis article was prepared as part of WisdomTree’s general paid sponsorship of VettaFi | ETF Trends. This specific content within and any opinions expressed therein belong solely to VettaFi and do not reflect the opinion or analysis of WisdomTree, its employees, or its affiliates. Content published on VettaFi | ETF Trends is provided for educational purposes only and should not be considered investment or tax advice. For investment or tax advice, please consult a financial professional.  WisdomTree is an independent company, unaffiliated with VettaFi | ETF Trends. WisdomTree has not been involved with the preparation of the content supplied by VettaFi | ETF Trends. It does not guarantee, or assume any responsibility for its content.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.